Jennifer Renee Fonda, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Veterans | 50 | 2024 | 2669 | 4.510 |
Why?
|
Stress Disorders, Post-Traumatic | 37 | 2024 | 4640 | 2.640 |
Why?
|
Blast Injuries | 8 | 2023 | 321 | 1.560 |
Why?
|
Afghan Campaign 2001- | 17 | 2022 | 298 | 1.260 |
Why?
|
Brain Concussion | 13 | 2024 | 1435 | 1.200 |
Why?
|
Military Personnel | 6 | 2023 | 1261 | 0.840 |
Why?
|
Post-Concussion Syndrome | 2 | 2022 | 257 | 0.770 |
Why?
|
September 11 Terrorist Attacks | 2 | 2019 | 107 | 0.740 |
Why?
|
Apolipoprotein E4 | 5 | 2024 | 712 | 0.590 |
Why?
|
Veterans Health | 1 | 2017 | 216 | 0.500 |
Why?
|
Tobacco Use Disorder | 1 | 2019 | 708 | 0.420 |
Why?
|
Depressive Disorder | 4 | 2021 | 3721 | 0.410 |
Why?
|
Suicide, Attempted | 2 | 2020 | 1409 | 0.330 |
Why?
|
Pain | 3 | 2022 | 5100 | 0.280 |
Why?
|
Brain Injuries | 3 | 2015 | 2057 | 0.270 |
Why?
|
Neuropsychological Tests | 12 | 2022 | 7140 | 0.240 |
Why?
|
Anger | 2 | 2024 | 405 | 0.230 |
Why?
|
Telemedicine | 1 | 2021 | 3109 | 0.230 |
Why?
|
United States Department of Veterans Affairs | 8 | 2018 | 937 | 0.210 |
Why?
|
Explosions | 2 | 2020 | 106 | 0.200 |
Why?
|
Depressive Disorder, Major | 2 | 2022 | 4818 | 0.200 |
Why?
|
United States | 20 | 2024 | 73039 | 0.190 |
Why?
|
Disabled Persons | 2 | 2022 | 1210 | 0.190 |
Why?
|
Cognition | 5 | 2021 | 7073 | 0.180 |
Why?
|
Nursing Theory | 1 | 2020 | 8 | 0.170 |
Why?
|
Cerebrovascular Circulation | 2 | 2020 | 2725 | 0.170 |
Why?
|
Cross-Sectional Studies | 12 | 2023 | 26379 | 0.170 |
Why?
|
Cognitive Reserve | 1 | 2020 | 92 | 0.170 |
Why?
|
Ocular Motility Disorders | 1 | 2021 | 144 | 0.170 |
Why?
|
Humans | 63 | 2024 | 768166 | 0.170 |
Why?
|
Craniocerebral Trauma | 1 | 2023 | 493 | 0.160 |
Why?
|
Male | 39 | 2024 | 364719 | 0.160 |
Why?
|
Myopia | 1 | 2021 | 254 | 0.150 |
Why?
|
Mental Health | 2 | 2024 | 3275 | 0.150 |
Why?
|
Adult | 29 | 2023 | 223646 | 0.150 |
Why?
|
Comorbidity | 5 | 2020 | 10590 | 0.150 |
Why?
|
Mental Disorders | 4 | 2020 | 6874 | 0.150 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2019 | 327 | 0.150 |
Why?
|
Combat Disorders | 1 | 2019 | 301 | 0.140 |
Why?
|
Analgesics, Opioid | 3 | 2020 | 3837 | 0.140 |
Why?
|
Female | 38 | 2024 | 397192 | 0.140 |
Why?
|
Longitudinal Studies | 7 | 2023 | 14783 | 0.130 |
Why?
|
Unemployment | 1 | 2018 | 211 | 0.130 |
Why?
|
Sex Offenses | 1 | 2020 | 357 | 0.130 |
Why?
|
Marital Status | 1 | 2017 | 426 | 0.130 |
Why?
|
Proton Pump Inhibitors | 2 | 2011 | 552 | 0.130 |
Why?
|
Education | 1 | 2018 | 533 | 0.120 |
Why?
|
Mood Disorders | 2 | 2019 | 1129 | 0.120 |
Why?
|
Drug Utilization Review | 1 | 2016 | 248 | 0.120 |
Why?
|
Kidney Diseases | 3 | 2010 | 2100 | 0.120 |
Why?
|
Medication Reconciliation | 1 | 2016 | 153 | 0.110 |
Why?
|
Attention | 3 | 2021 | 2424 | 0.110 |
Why?
|
Executive Function | 2 | 2020 | 1401 | 0.110 |
Why?
|
Interview, Psychological | 1 | 2017 | 810 | 0.110 |
Why?
|
Self Concept | 1 | 2020 | 1043 | 0.110 |
Why?
|
Polypharmacy | 1 | 2016 | 307 | 0.110 |
Why?
|
Guideline Adherence | 2 | 2016 | 2235 | 0.110 |
Why?
|
Gyrus Cinguli | 2 | 2021 | 1135 | 0.110 |
Why?
|
Prevalence | 4 | 2019 | 15869 | 0.100 |
Why?
|
Cognition Disorders | 2 | 2018 | 3980 | 0.100 |
Why?
|
Heterozygote | 1 | 2019 | 2798 | 0.100 |
Why?
|
Dementia | 2 | 2024 | 2740 | 0.100 |
Why?
|
Anxiety Disorders | 3 | 2019 | 2748 | 0.100 |
Why?
|
Prefrontal Cortex | 2 | 2021 | 2238 | 0.100 |
Why?
|
Overweight | 1 | 2023 | 2448 | 0.100 |
Why?
|
Alzheimer Disease | 2 | 2022 | 8759 | 0.090 |
Why?
|
Burnout, Professional | 1 | 2020 | 711 | 0.090 |
Why?
|
Somatosensory Cortex | 1 | 2014 | 516 | 0.090 |
Why?
|
Cohort Studies | 9 | 2024 | 41754 | 0.090 |
Why?
|
Anemia | 2 | 2010 | 1514 | 0.090 |
Why?
|
Hematinics | 2 | 2010 | 282 | 0.090 |
Why?
|
Depression | 5 | 2022 | 8230 | 0.090 |
Why?
|
Alcoholism | 1 | 2021 | 1980 | 0.080 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3858 | 0.080 |
Why?
|
Pneumonia, Bacterial | 1 | 2011 | 320 | 0.080 |
Why?
|
Middle Aged | 20 | 2023 | 223492 | 0.080 |
Why?
|
Research Design | 1 | 2024 | 6211 | 0.070 |
Why?
|
Patient Compliance | 1 | 2018 | 2697 | 0.070 |
Why?
|
Schizophrenic Psychology | 1 | 2015 | 1649 | 0.070 |
Why?
|
Community-Acquired Infections | 1 | 2011 | 472 | 0.070 |
Why?
|
Disability Evaluation | 1 | 2015 | 1835 | 0.070 |
Why?
|
Hemoglobins | 2 | 2010 | 1531 | 0.070 |
Why?
|
Motor Cortex | 1 | 2014 | 1013 | 0.070 |
Why?
|
Drug Prescriptions | 1 | 2016 | 1668 | 0.070 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2010 | 496 | 0.070 |
Why?
|
Quality of Life | 3 | 2023 | 13490 | 0.070 |
Why?
|
Cardiovascular Diseases | 2 | 2023 | 15662 | 0.070 |
Why?
|
Pain Measurement | 1 | 2016 | 3583 | 0.060 |
Why?
|
Young Adult | 11 | 2023 | 60066 | 0.060 |
Why?
|
Retrospective Studies | 11 | 2024 | 81762 | 0.060 |
Why?
|
Perfusion | 2 | 2020 | 1401 | 0.060 |
Why?
|
Prospective Studies | 4 | 2024 | 54926 | 0.060 |
Why?
|
Gadolinium | 1 | 2010 | 964 | 0.060 |
Why?
|
Ambulatory Care | 1 | 2016 | 2783 | 0.060 |
Why?
|
Anxiety | 1 | 2020 | 4672 | 0.060 |
Why?
|
Cerebral Cortex | 1 | 2021 | 5812 | 0.060 |
Why?
|
Weight Gain | 1 | 2015 | 2359 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 8 | 2022 | 36743 | 0.060 |
Why?
|
Factor Analysis, Statistical | 2 | 2018 | 1001 | 0.060 |
Why?
|
Age of Onset | 2 | 2021 | 3347 | 0.060 |
Why?
|
Blood Transfusion | 1 | 2010 | 1309 | 0.050 |
Why?
|
Clostridium Infections | 1 | 2010 | 562 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12543 | 0.050 |
Why?
|
Nerve Net | 1 | 2014 | 2352 | 0.050 |
Why?
|
Genotype | 3 | 2022 | 13045 | 0.050 |
Why?
|
Survivors | 2 | 2023 | 2381 | 0.050 |
Why?
|
United States Food and Drug Administration | 1 | 2010 | 1673 | 0.050 |
Why?
|
Diffusion Tensor Imaging | 2 | 2023 | 2420 | 0.050 |
Why?
|
Adolescent | 8 | 2023 | 89169 | 0.050 |
Why?
|
Aged | 14 | 2024 | 171504 | 0.050 |
Why?
|
Antipsychotic Agents | 1 | 2015 | 3081 | 0.050 |
Why?
|
Biomedical Research | 1 | 2017 | 3463 | 0.050 |
Why?
|
Registries | 1 | 2017 | 8375 | 0.050 |
Why?
|
Incidence | 2 | 2017 | 21538 | 0.050 |
Why?
|
Punishment | 1 | 2021 | 95 | 0.050 |
Why?
|
Obesity | 1 | 2023 | 13090 | 0.040 |
Why?
|
Brain | 6 | 2023 | 27360 | 0.040 |
Why?
|
Renal Dialysis | 1 | 2010 | 1791 | 0.040 |
Why?
|
Psychology, Social | 1 | 2020 | 52 | 0.040 |
Why?
|
Models, Nursing | 1 | 2020 | 47 | 0.040 |
Why?
|
Students, Nursing | 1 | 2020 | 46 | 0.040 |
Why?
|
Sleep | 1 | 2015 | 4819 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7454 | 0.040 |
Why?
|
Adaptation, Psychological | 2 | 2020 | 2663 | 0.040 |
Why?
|
New England | 2 | 2011 | 1058 | 0.040 |
Why?
|
Logistic Models | 3 | 2021 | 13290 | 0.040 |
Why?
|
Regression Analysis | 2 | 2018 | 6340 | 0.040 |
Why?
|
Ethanol | 1 | 2023 | 1331 | 0.040 |
Why?
|
Water | 1 | 2023 | 1421 | 0.040 |
Why?
|
Alcohol Drinking | 2 | 2023 | 4045 | 0.030 |
Why?
|
Contrast Media | 1 | 2010 | 5330 | 0.030 |
Why?
|
Dextropropoxyphene | 1 | 2016 | 26 | 0.030 |
Why?
|
Aged, 80 and over | 6 | 2024 | 59629 | 0.030 |
Why?
|
Trauma Severity Indices | 1 | 2018 | 479 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2018 | 6029 | 0.030 |
Why?
|
Self Report | 2 | 2020 | 3773 | 0.030 |
Why?
|
Schizophrenia | 1 | 2015 | 6983 | 0.030 |
Why?
|
Organ Size | 1 | 2021 | 2267 | 0.030 |
Why?
|
Parietal Lobe | 1 | 2021 | 866 | 0.030 |
Why?
|
Physical Fitness | 1 | 2020 | 744 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2022 | 1758 | 0.030 |
Why?
|
Models, Psychological | 1 | 2020 | 825 | 0.030 |
Why?
|
Rest | 1 | 2020 | 948 | 0.030 |
Why?
|
Hospitalization | 1 | 2015 | 10840 | 0.030 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2021 | 1988 | 0.030 |
Why?
|
Apolipoproteins E | 1 | 2021 | 1461 | 0.030 |
Why?
|
Oxycodone | 1 | 2016 | 144 | 0.030 |
Why?
|
Reward | 1 | 2021 | 981 | 0.030 |
Why?
|
Task Performance and Analysis | 1 | 2018 | 771 | 0.030 |
Why?
|
Atrophy | 1 | 2019 | 1646 | 0.030 |
Why?
|
Fentanyl | 1 | 2016 | 451 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2016 | 969 | 0.030 |
Why?
|
Brain Mapping | 2 | 2020 | 6685 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2022 | 4249 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2022 | 3228 | 0.020 |
Why?
|
Substance-Related Disorders | 2 | 2021 | 4423 | 0.020 |
Why?
|
Glomerular Filtration Rate | 2 | 2010 | 2227 | 0.020 |
Why?
|
Continuity of Patient Care | 1 | 2018 | 1078 | 0.020 |
Why?
|
Risk | 2 | 2015 | 9613 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2016 | 1443 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15948 | 0.020 |
Why?
|
Pilot Projects | 1 | 2023 | 8741 | 0.020 |
Why?
|
Iron Compounds | 1 | 2010 | 28 | 0.020 |
Why?
|
Social Support | 1 | 2020 | 2193 | 0.020 |
Why?
|
Neural Pathways | 1 | 2020 | 3117 | 0.020 |
Why?
|
Risk Factors | 3 | 2024 | 74944 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2020 | 22291 | 0.020 |
Why?
|
Risk Assessment | 3 | 2018 | 24315 | 0.020 |
Why?
|
Databases, Factual | 2 | 2016 | 8080 | 0.020 |
Why?
|
Prescription Drugs | 1 | 2015 | 635 | 0.020 |
Why?
|
Propensity Score | 1 | 2015 | 1969 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2018 | 5315 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4860 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2022 | 9538 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2023 | 4887 | 0.020 |
Why?
|
Chronic Disease | 2 | 2010 | 9384 | 0.010 |
Why?
|
Phenotype | 1 | 2022 | 16726 | 0.010 |
Why?
|
Creatinine | 1 | 2010 | 1918 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2016 | 3573 | 0.010 |
Why?
|
Drug Utilization | 1 | 2010 | 1189 | 0.010 |
Why?
|
Boston | 1 | 2017 | 9374 | 0.010 |
Why?
|
Aging | 1 | 2022 | 8744 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20227 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2020 | 9015 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2022 | 12795 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9669 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12077 | 0.010 |
Why?
|
Hospitals | 1 | 2015 | 3886 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15454 | 0.010 |
Why?
|
Length of Stay | 1 | 2015 | 6498 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10873 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2022 | 18065 | 0.010 |
Why?
|
Quality Improvement | 1 | 2015 | 3857 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2010 | 6316 | 0.010 |
Why?
|
Pneumonia | 1 | 2011 | 2163 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 16045 | 0.010 |
Why?
|
Patient Selection | 1 | 2010 | 4260 | 0.010 |
Why?
|
Recurrence | 1 | 2010 | 8509 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 30010 | 0.010 |
Why?
|
Survival Analysis | 1 | 2010 | 10101 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2010 | 39348 | 0.000 |
Why?
|
Time Factors | 1 | 2010 | 40218 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2010 | 65371 | 0.000 |
Why?
|